Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation

Somatic hypermutation and clonal selection lead to B cells expressing high-affinity antibodies. Here we show that somatic mutations not only play a critical role in antigen binding, they also affect the thermodynamic stability of the antibody molecule. Somatic mutations directly involved in antigen recognition by antibody 93F3, which binds a relatively small hapten, reduce the melting temperature compared with its germ-line precursor by up to 9 °C. The destabilizing effects of these mutations are compensated by additional somatic mutations located on surface loops distal to the antigen binding site. Similarly, somatic mutations enhance both the affinity and thermodynamic stability of antibody OKT3, which binds the large protein antigen CD3. Analysis of the crystal structures of 93F3 and OKT3 indicates that these somatic mutations modulate antibody stability primarily through the interface of the heavy and light chain variable domains. The historical view of antibody maturation has been that somatic hypermutation and subsequent clonal selection increase antigen–antibody specificity and binding energy. Our results suggest that this process also optimizes protein stability, and that many peripheral mutations that were considered to be neutral are required to offset deleterious effects of mutations that increase affinity. Thus, the immunological evolution of antibodies recapitulates on a much shorter timescale the natural evolution of enzymes in which function and thermodynamic stability are simultaneously enhanced through mutation and selection.

[1]  John McCafferty,et al.  Beyond natural antibodies: the power of in vitro display technologies , 2011, Nature Biotechnology.

[2]  Peter G. Schultz,et al.  The interplay between binding energy and catalysis in the evolution of a catalytic antibody , 1997, Nature.

[3]  Najeeb M. Halabi,et al.  Protein Sectors: Evolutionary Units of Three-Dimensional Structure , 2009, Cell.

[4]  W. Huse,et al.  Optimization of protein therapeutics by directed evolution. , 2003, Drug discovery today.

[5]  J. D. De Mey,et al.  OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. , 1980, Journal of immunology.

[6]  Wei Liu,et al.  High‐throughput measurement, correlation analysis, and machine‐learning predictions for pH and thermal stabilities of Pfizer‐generated antibodies , 2011, Protein science : a publication of the Protein Society.

[7]  S. Steinbacher,et al.  Sequence statistics reliably predict stabilizing mutations in a protein domain. , 1994, Journal of molecular biology.

[8]  S. Tonegawa,et al.  Somatic generation of antibody diversity. , 1976, Nature.

[9]  R. Lerner,et al.  Direct observation of an enamine intermediate in amine catalysis. , 2009, Journal of the American Chemical Society.

[10]  N. D. Da Silva,et al.  Relationship between thermal stability, degradation rate and expression yield of barnase variants in the periplasm of Escherichia coli. , 1996, Protein engineering.

[11]  A. Plückthun,et al.  Selection for improved protein stability by phage display. , 1999, Journal of molecular biology.

[12]  L. K. Ely,et al.  Crystal structure of the human T cell receptor CD3 epsilon gamma heterodimer complexed to the therapeutic mAb OKT3. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Peter G. Schultz,et al.  The Immunological Evolution of Catalysis , 1996, Science.

[14]  Hugues Bedouelle,et al.  Improving the stability of an antibody variable fragment by a combination of knowledge-based approaches: validation and mechanisms. , 2006, Journal of molecular biology.

[15]  Orly Dym,et al.  Following evolutionary paths to protein-protein interactions with high affinity and selectivity , 2009, Nature Structural &Molecular Biology.

[16]  A. Plückthun,et al.  Beyond binding: using phage display to select for structure, folding and enzymatic activity in proteins. , 1999, Current opinion in structural biology.

[17]  P. Schultz,et al.  Structural and kinetic evidence for strain in biological catalysis. , 1998, Biochemistry.

[18]  T. T. Wu,et al.  AN ANALYSIS OF THE SEQUENCES OF THE VARIABLE REGIONS OF BENCE JONES PROTEINS AND MYELOMA LIGHT CHAINS AND THEIR IMPLICATIONS FOR ANTIBODY COMPLEMENTARITY , 1970, The Journal of experimental medicine.

[19]  F. Burnet The clonal selection theory of acquired immunity , 1959 .

[20]  R. Fuller,et al.  The origin of enantioselectivity in aldolase antibodies: crystal structure, site-directed mutagenesis, and computational analysis. , 2004, Journal of molecular biology.

[21]  N. K. Jerne,et al.  THE NATURAL-SELECTION THEORY OF ANTIBODY FORMATION. , 1955, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Bluestone,et al.  Humanized OKT3 antibodies: successful transfer of immune modulating properties and idiotype expression. , 1992, Journal of Immunology.

[23]  Brian K Shoichet,et al.  Evolution of an antibiotic resistance enzyme constrained by stability and activity trade-offs. , 2002, Journal of molecular biology.

[24]  Sanjay B. Hari,et al.  High-throughput thermal scanning: a general, rapid dye-binding thermal shift screen for protein engineering. , 2009, Journal of the American Chemical Society.

[25]  Peter G Schultz,et al.  Structural evidence for substrate strain in antibody catalysis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  Hyunbo Shim,et al.  Evolution of aldolase antibodies in vitro: correlation of catalytic activity and reaction-based selection. , 2004, Journal of molecular biology.

[27]  R. Lerner,et al.  Efficient Aldolase Catalytic Antibodies That Use the Enamine Mechanism of Natural Enzymes , 1995, Science.

[28]  P. Schultz,et al.  Immunological origins of binding and catalysis in a Diels-Alderase antibody. , 1998, Science.

[29]  Linda O Narhi,et al.  High throughput thermostability screening of monoclonal antibody formulations. , 2010, Journal of pharmaceutical sciences.

[30]  Dan S. Tawfik,et al.  Stability effects of mutations and protein evolvability. , 2009, Current opinion in structural biology.

[31]  A. Plückthun,et al.  Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides. , 2000, Journal of molecular biology.

[32]  A. Plückthun,et al.  Mutual stabilization of VL and VH in single-chain antibody fragments, investigated with mutants engineered for stability. , 1998, Biochemistry.

[33]  M. Matsumura,et al.  Screening for thermostable mutant of kanamycin nucleotidyltransferase by the use of a transformation system for a thermophile, Bacillus stearothermophilus. , 1985, The Journal of biological chemistry.

[34]  T. Beddoe,et al.  Crystal structure of the human T cell receptor CD3εγ heterodimer complexed to the therapeutic mAb OKT3 , 2004 .

[35]  Dan S. Tawfik,et al.  Mutational effects and the evolution of new protein functions , 2010, Nature Reviews Genetics.

[36]  G. Teng,et al.  Immunoglobulin somatic hypermutation. , 2007, Annual review of genetics.

[37]  Mark M. Davis,et al.  Antibody diversity: Somatic hypermutation of rearranged VH genes , 1981, Cell.

[38]  Andreas Plückthun,et al.  Biophysical properties of human antibody variable domains. , 2003, Journal of molecular biology.